JS

Jyothinagaravyasha Sriraman Ramaprasad

Active Director Designated Partner DIN 00173696
DIN 00173696 First appointment Feb 2005 Primary industry Business Outsourcing
Unlock full profile Investments · shareholding · contact details
Current companies 15 active board seats
Past companies 37 historical roles
Total affiliations 52 Since Feb 2005
Shareholding value •••• Premium profile

About Jyothinagaravyasha Sriraman Ramaprasad

Data last updated:

Jyothinagaravyasha Sriraman Ramaprasad is a Designated Partner at Pronomz Ventures Llp (since 2011), Designated Partner at Agnus Capital Llp (since 2012) and Director at Hydra Active Pharma Sciences Private Limited (since 2016), and holds 12 more current directorships. The companies operate in Business Outsourcing, Pharma and Healthcare. The 5 current companies with reported revenue have a combined latest revenue of ₹43.10 Cr; the largest is Pronomz Ventures Llp at ₹21.31 Cr (FY 2020). Earlier, Jyothinagaravyasha Sriraman Ramaprasad was a Designated Partner at Qualichem Remedies Llp (2012–2025) and Director at Karuna Ventures Private Limited (2009–2017) and 35 more.

DIN 00173696
Primary Designation Designated Partner
Industry Business Outsourcing
First Appointment 16 Feb 2005
Oldest Company Age 40 yrs
Largest company Pronomz Ventures Llp · ₹21.31 Cr (FY 2020)
Combined revenue ₹43.10 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner09 Feb 20112011₹21.31 Cr (FY 2020)Active
Designated Partner19 Nov 20122010₹18.21 Cr (FY 2023)Active
Director06 Dec 20162016₹1.97 Cr (FY 2023)Active
Director24 Dec 20222013₹1.47 Cr (FY 2025)Active
Designated Partner19 Nov 20122010₹13.1 Lakh (FY 2023)Active
Designated Partner07 Jan 20142014Active
Designated Partner25 Sep 20242020Active
Designated Partner06 May 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner19 Nov 20122010Active
Karuna Ventures Private Limited U74110KA2009PTC050575
Director07 Aug 20092009₹1.92 Cr (FY 2025)Active
Sequent Research Limited U24232TS2007PLC196886
Director13 Apr 20072007₹9.52 Cr (FY 2025)Amalgamated
Skanray Healthcare Private Limited U85100KA2010PTC054613
Director31 Mar 20122010Amalgamated
Director25 May 20112010Strike Off
Elysian Health Care Private Limited U24230KA2010PTC053004
Director01 Dec 20112010₹7.84 Cr (FY 2025)Active
Director01 Jul 20162016₹1,071 Cr (FY 2024)Active
Chayadeep Properties Private Limited U45203KA2003PTC094179
Director27 Apr 20062003₹16.74 Cr (FY 2025)Active
Designated Partner28 Jan 20212014Strike Off
Designated Partner19 Nov 20122010Strike Off
Designated Partner19 Nov 20122010Strike Off
Designated Partner22 Jun 20212019Strike Off
Farmgenus Private Limited U01100KA2019PTC125793
Director02 Jul 20192019Strike Off
Xlensea Products Private Limited U05001KA1998PTC024577
Director27 Apr 20061998Amalgamated
Netequity Ventures Private Limited U06592KA1999PTC026028
Director16 Feb 20051999Amalgamated
Fraxis Life Sciences Limited U24117MH2007PLC210962
Director11 Mar 20092007Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Jyothinagaravyasha Sriraman Ramaprasad

Directorship timeline

Open interactive timeline →
Rivela Developers Llp
Pronomz Ventures Llp
Skanray Healthcare Partners Llp
Atma Enterprises Llp
Premium access

Shareholding and investment profile for Jyothinagaravyasha Sriraman Ramaprasad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyothinagaravyasha Sriraman Ramaprasad

Jyothinagaravyasha Sriraman Ramaprasad currently holds 15 directorships: Pronomz Ventures Llp (Designated Partner, since 09 Feb 2011, revenue ₹21.31 Cr (FY 2020)); Agnus Capital Llp (Designated Partner, since 19 Nov 2012, revenue ₹18.21 Cr (FY 2023)); Hydra Active Pharma Sciences Private Limited (Director, since 06 Dec 2016, revenue ₹1.97 Cr (FY 2023)); Skanray Healthcare Global Private Limited (Director, since 24 Dec 2022, revenue ₹1.47 Cr (FY 2025)); Chayadeep Ventures Llp (Designated Partner, since 19 Nov 2012, revenue ₹13.1 Lakh (FY 2023)); and 10 more.

Jyothinagaravyasha Sriraman Ramaprasad was first appointed on 16 Feb 2005 as Director at Netequity Ventures Private Limited. The most recent appointment on record is 25 Sep 2024 at Foursquare Pharma Solutions Llp.

The 5 current companies of Jyothinagaravyasha Sriraman Ramaprasad that report revenue have a combined latest revenue of ₹43.10 Cr: Pronomz Ventures Llp ₹21.31 Cr (FY 2020); Agnus Capital Llp ₹18.21 Cr (FY 2023); Hydra Active Pharma Sciences Private Limited ₹1.97 Cr (FY 2023); Skanray Healthcare Global Private Limited ₹1.47 Cr (FY 2025); Chayadeep Ventures Llp ₹13.1 Lakh (FY 2023).

Jyothinagaravyasha Sriraman Ramaprasad held 37 earlier board appointments: Qualichem Remedies Llp (Designated Partner, 19 Nov 2012 to 26 May 2025); Karuna Ventures Private Limited (Director, 07 Aug 2009 to 02 Mar 2017); Sequent Research Limited (Director, 13 Apr 2007 to 10 Aug 2015); Skanray Healthcare Private Limited (Director, 31 Mar 2012 to 04 Feb 2013); Elysian Life Sciences Private Limited (Director, 25 May 2011 to 10 May 2017); and 32 more.

The current boards of Jyothinagaravyasha Sriraman Ramaprasad's companies include Chandrappa Seetharamaiah (Pronomz Ventures Llp), Arun Kumar Pillai (Agnus Capital Llp), K R Ravishankar (Agnus Capital Llp), Kavita Swame (Skanray Healthcare Global Private Limited), Lakshmi Dayanand Kamath (Skanray Healthcare Global Private Limited), Sowmya Kiran (Skanray Healthcare Global Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available